New combo therapy trial aims to bring back skin color for vitiligo patients
NCT ID NCT07152626
First seen Nov 01, 2025 · Last updated Apr 19, 2026 · Updated 24 times
Summary
This study is testing whether a daily pill called ritlecitinib works better for vitiligo when combined with twice-weekly UV light treatments. It will involve 56 adults with non-segmental vitiligo for 52 weeks to see which approach leads to more repigmentation on the face and body. The goal is to find a more effective way to manage the condition and improve skin appearance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHu de Nice, Hôpital Archet
Nice, Alpes-Maritime, 06200, France
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.